2-哌啶酮,4-(1,1-二甲基乙基)-1-羟基- | 118972-10-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 2-哌啶酮,4-(1,1-二甲基乙基)-1-羟基-
• 英文名称: 4-Tert-butyl-1-hydroxypiperidin-2-one
• CAS: 118972-10-4
• 化学式: C₉H₁₇NO₂
• 分子量: 171.239
• InChiKey: XVZFOUXOKNSVBI-UHFFFAOYSA-N

物化性质

• 沸点：
  260.1±23.0 °C(Predicted)
• 密度：
  1.088±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  40.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  (+/-)-4-tert-Butyl-3,4,5,6-tetrahydropyridin-1-oxid 在 Hg(II)-EDTA 作用下， 以 二氯甲烷 为溶剂， 反应 24.0h， 以79%的产率得到2-哌啶酮,4-(1,1-二甲基乙基)-1-羟基-
  参考文献：
  名称：

  Wenkert, Ernest; Angell, E. Charles, Synthetic Communications, 1988, vol. 18, # 12, p. 1331 - 1338

  摘要：

  DOI：

文献信息

• WENKERT, ERNEST;ANGELL, E. CHARLES, SYNTH. COMMUN., 18,(1988) N 12, C. 1331-1337
  作者：WENKERT, ERNEST、ANGELL, E. CHARLES

  DOI：——

  日期：——
• Novel soluble 1,4 benzodiazepine compounds and stable salts thereof
  申请人：Durrani Manzer

  公开号：US20080064686A1

  公开（公告）日：2008-03-13

  The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and related compounds and methods of using benzodiazepine derivatives and related compounds as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, hyperproliferation, and the like.
• Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof
  申请人：Durrani Manzer

  公开号：US20110009393A1

  公开（公告）日：2011-01-13

  The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and related compounds and methods of using benzodiazepine derivatives and related compounds as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, hyperproliferation, and the like.
• US7759338B2
  申请人：——

  公开号：US7759338B2

  公开（公告）日：2010-07-20
• Wenkert, Ernest; Angell, E. Charles, Synthetic Communications, 1988, vol. 18, # 12, p. 1331 - 1338
  作者：Wenkert, Ernest、Angell, E. Charles

  DOI：——

  日期：——